Previous close | 0.7300 |
Open | 0.7300 |
Bid | 0.0000 |
Ask | 4.9500 |
Strike | 90.00 |
Expiry date | 2025-06-20 |
Day's range | 0.7300 - 0.7300 |
Contract range | N/A |
Volume | |
Open interest | 1 |
AbbVie (NYSE: ABBV) today announced that the independent directors of the board have selected Roxanne S. Austin as lead independent director, effective July 1, 2024. Ms. Austin succeeds Glenn F. Tilton, who has served as lead independent director since 2013. Mr. Tilton will continue to serve on the AbbVie Board as an independent director.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.